Measurement of Aortic Valve Coaptation and Effective Height Using Echocardiography in Patients with Ventricular

Satoru Iwashima1, Hiroki Uchiyama2, Takamichi Ishikawa2

  • 1Department of Pediatrics, Chutoen General Medical Center, Syoubugauraike 1-1, Kakegawa City, 436-8555, Japan. iwashima3617@gmail.com.

Pediatric Cardiology
|January 22, 2017
PubMed

Insights

New echocardiographic indices, aortic cusp coaptation height (ACH) and effective height (AEH), can assess aortic cusp prolapse severity in children with ventricular septal defects. These measurements may guide surgical intervention decisions.

Area of Science:

  • Pediatric Cardiology
  • Echocardiography
  • Congenital Heart Disease

Background:

  • Decreased aortic valve coaptation height is a known indicator of valve failure in adults.
  • Ventricular septal defects (VSD) can be associated with aortic cusp prolapse (ACP) and subsequent aortic regurgitation (AR).

Purpose of the Study:

  • To evaluate aortic valve coaptation height (CH) and effective height (EH) in healthy children and those with VSD and ACP using echocardiography.
  • To assess the utility of novel ACH and AEH indices in determining the severity of VSD with ACP and guiding surgical intervention.

Main Methods:

  • Echocardiography was used to measure aortic valve diameter (AV), CH, and EH in 83 healthy controls and 45 children with VSD and ACP (18 developed AR, 27 did not).
  • Aortic root anatomy was assessed, and ACH (CH/AV ratio) and AEH (EH/AV ratio) indices were calculated.
  • Measurements were compared between groups, and changes in ACH and AEH were analyzed before and after intra-cardiac repair (ICR) in 15 cases.

Main Results:

  • Significant differences in ACH and AEH were observed between control, VSD with ACP, and VSD with ACP and AR groups (P < 0.01).
  • Median ACH decreased from 35.1% in controls to 32.0% in VSD with ACP and 22.1% in VSD with ACP and AR.
  • Median AEH decreased from 52.0% in controls to 48.0% in VSD with ACP and 34.4% in VSD with ACP and AR.
  • Following ICR, significant increases in ACH (27.0% to 32.7%) and AEH (38.5% to 45.8%) were noted (P < 0.05).

Conclusions:

  • ACH and AEH are valuable non-invasive echocardiographic markers for assessing the severity of VSD with ACP.
  • These indices can assist clinicians in determining the optimal timing for surgical intervention in affected children.

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
729
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
987
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
898
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
373
Imaging Studies for Cardiovascular System II:Types of Echocardiography01:20

Imaging Studies for Cardiovascular System II:Types of Echocardiography

Echocardiography plays a role in assessing cardiac health and detecting heart conditions, with various types providing critical insights for diagnosis and treatment.
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
750
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
528